Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study.
Grever
M R
MR
Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Crowley
J
J
Salmon
S
S
McGee
R
R
Kraut
E H
EH
Buys
S S
SS
Rivkin
S E
SE
D000368:Aged; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D015649:Pentostatin / Q000627:therapeutic use* / Q000633:toxicity
D015649:Pentostatin; D003404:Creatinine